This federal contract award, valued at $34,560.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order with a firm fixed-price pricing type, and no set-aside designation. Cepheid will provide its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of various infectious diseases, including COVID-19, influenza, and...
The federal contract award with ID SPE2DE24D0013|SPE2D625F30ZG was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $1,155.00 firm fixed-price delivery order contract is for Cepheid to provide molecular diagnostic testing equipment, reagents, and consumables to support the detection of infectious diseases such as COVID-19, influenza, and other clinical conditions. This award is part of a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract, valued at $1,605.00, is a firm fixed-price delivery order with no set-aside designation. It is associated with a larger Indefinite Delivery Contract (IDC) vehicle with the DLA. Under this contract, Cepheid will provide molecular diagnostic testing equipment, reagents, test kits, and maintenance services...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $2,040.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is not...
The U.S. Defense Logistics Agency (DLA) awarded a $2,737.80 firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has an ultimate completion date of January 3, 2025 and was awarded on December 26, 2024. The award does not have a set-aside designation. Cepheid is a prime contractor and original equipment manufacturer that has received numerous federal contracts and grants to provide diagnostic testing equipment, reagents,...
This federal contract award to Cepheid Inc. (Cepheid), a for-profit manufacturer of molecular diagnostic solutions, is a Firm Fixed Price delivery order contract valued at $7,480.00. The contract was awarded by the Defense Logistics Agency (DLA), an agency within the Department of Defense, to provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, reagents, test kits, and maintenance services, for the detection of various infectious diseases such as COVID-19,...
This federal contract award, worth up to $204,000.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order, with no set-aside designation. Cepheid will provide the agency with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions enable the rapid detection and diagnosis of various infectious diseases, including...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, was issued by the Defense Logistics Agency (DLA) for the supply of diagnostic testing equipment, reagents, and consumables for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract, valued at $27,200.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid holds several significant federal contract Indefinite Delivery...
This federal contract award, valued at $2,944.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. Cepheid is providing the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and other conditions. Cepheid has a...
This federal contract award, valued at $5,530.08, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order with a firm fixed price and an ultimate completion date of November 13, 2024. The award does not have a set-aside designation, indicating Cepheid was the prime contractor selected. Based on the description, this contract is likely part of the Department of...